New insider activity at CVS Health ( (CVS) ) has taken place on August 29, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Director Anne Finucane recently sold 7,500 shares of CVS Health stock, generating a total of $532,650 from the transaction.
Spark’s Take on CVS Stock
According to Spark, TipRanks’ AI Analyst, CVS is a Outperform.
CVS Health’s strong technical momentum and positive earnings outlook are the most significant factors driving the score. While financial performance is solid, there is room for improvement in profitability. The valuation is reasonable, and the earnings call provided a positive outlook despite some challenges.
To see Spark’s full report on CVS stock, click here.
More about CVS Health
YTD Price Performance: 66.22%
Average Trading Volume: 7,397,182
Technical Sentiment Signal: Buy
Current Market Cap: $91.5B